Pilot quality assurance programme for plasma metanephrines

Annals of Clinical Biochemistry

Volumn 47, Issue 2, 2010, Pages 137-142

  Pillai, Dilo ^a   Callen, Shaw ^b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b RCPA Chemical Pathology Quality Assurance Programs   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3 O METHYLDOPAMINE; METADRENALIN; NORMETADRENALIN;

ARTICLE; BLOOD SAMPLING; FREEZE DRYING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PILOT STUDY; PRIORITY JOURNAL; QUALITY CONTROL; TANDEM MASS SPECTROMETRY; URINALYSIS;

BIOGENIC AMINES; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; FEASIBILITY STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; METANEPHRINE; NORMETANEPHRINE; PILOT PROJECTS; QUALITY CONTROL; REFERENCE STANDARDS; TANDEM MASS SPECTROMETRY;

EID: 77749327332     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2009.009153     Document Type: Article

References (13)

1. Lenders JW, Pacaek K, Walther MM, et al. Biochemical diagnosis of phaeochromocytoma: which test is best? JAMA 2002;287: 1427-34
2. Peaston RT, Ball S. Biochemical detection of phaeochromocytoma: why are we continuing to ignore the evidence? Ann Clin Biochem 2008; 45:6-10
3. Vaclavik J, Stejskal D, Lacnak B, et al. Free plasma metanephrines as a screening test for phaeochromocytoma in low-risk patients. J Hypertension 2007;25:1427-31
4. Hickman PE, Leong M, Chang J, et al. Plasma free metanephrines are superior to urine and plasma catecholamine metabolites for the investigation of phaeochromocytoma. Pathology 2009;41:173-77
5. Whiting MJ, Doogue MP. Advances in biochemical screening for phaeochromocytoma using biogenic amines. Clin Biochem Rev 2009;30:3-17
6. Pacak K, Eisenhofer G, Ahlman H, et al. Phaeochromocytoma: recommendations for clinical practice from the first international symposium. Nat Clin Pract Endocr Metab 2007;3:92-103
7. Lenders JWM, Eisenhofer G, Armando I, et al. Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin Chem 1993;39:97-103
8. Unger N, Pitt C, Schmidt I, et al. Diagnostic value of various biochemical parameters for the diagnosis of phaeochromocytoma in patients with adrenal mass. Eur J Endocr 2006;154:409-7
9. Lenz T, Zorner J, Kirchmaier C, et al. Multicenter study on the diagnostic value of free plasma metanephrines in the work-up for phaeochromocytoma. Ann N Y Acad Sci 2006;1073:358-73
10. Lagerstedt SA, O'Kane DJ, Singh RJ. Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma. Clin Chem 2004;50:603-11
11. de Jong WHA, Graham KS, van der Molen JC, et al. Plasma free metanephrine measurement using automated online solid phase extraction HPLC-tandem mass spectrometry. Clin Chem 2007;53: 1684-93
12. Grouzmann E, Pillai D, Ross HA, et al. Proficiency test of plasma free and total metanephrines: report from a study group. Clin Chem Lab Med 2009;47:786-90
13. Eisenhofer G, Goldstein DS, Sullivan P, et al. Biochemical and clinical manifestations of dopamine producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 2005;90: 2068-75